TREATMENT WITH RADIOPHARMACEUTICAL XOFIGO®

xofigoWhat does treatment with radiopharmaceutical XOFIGO® mean?

It is a pharmacological method for treating prostate cancer using the radiopharmaceutical XOFIGO®. HIFU CLINIC Prostate Cancer Treatment Centre is the only medical centre in Poland offering privately paid treatment with a medicinal product XOFIGO®. This medicine contains an active substance, radium dichloride, Ra-223.

What does the therapy involve?

The medicinal product XOFIGO® is administered at 4 weeks intervals, as 6 injections. XOFIGO®, i.e., radium 223, reaches bones where cancer metastases are located, and emits short-range radiation destroying cancer cells without damaging bone marrow.

The radiopharmaceutical XOFIGO® should only be administered by personnel authorised to use formulations of this type, at designated clinical centres, and after Patient's health is examined by a qualified doctor.

 

Who is this therapy for?

This therapy is intended for Patients with bone metastatic castrate-resistant prostate cancer. At this stage cancer does not respond to treatment reducing levels of male sex hormones, and is characterised by symptomatic (e.g., pain) metastases to bones without signs of disease spreading to other organs.

How can I arrange the therapy?

More information on urological treatment can be found at www.szpitalse.pl.


See also

HIFU method – prostate cancer treatment

High Intensity Focused Ultrasound – innovative, minimally invasive method of prostate cancer treatment...

More
International clinical studies

Urologists and oncologists at the best medical centres in Europe and the United States...

More
Open Radical Prostatectomy

Open radical prostatectomy is a surgical procedure performed on patients with prostate cancer, in case of a disease limited to prostate.

More
Do you have any questions or need more information?Contact us >>